Clinical trial · Observational
Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer
Integration of Palliative Care in Use of Intra-Peritoneal Chemotherapy for Ovarian Cancer
NCT00804258CI-TRIAL-00019725completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Palliative care may help improve the quality of life of patients with ovarian cancer who are undergoing intraperitoneal chemotherapy. PURPOSE: This clinical trial is studying palliative care in patients with ovarian cancer who are undergoing intraperitoneal chemotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (8)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| assessment of therapy complications | Procedure | — | UNRESOLVED |
| educational intervention | Other | — | UNRESOLVED |
| end-of-life treatment/management | Procedure | — | UNRESOLVED |
| intraperitoneal chemotherapy | Drug | — | UNRESOLVED |
| medical chart review | Other | — | UNRESOLVED |
| psychosocial assessment and care | Procedure | — | UNRESOLVED |
| quality-of-life assessment | Procedure | — | UNRESOLVED |
| questionnaire administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (5)
- measure
- Symptoms/concerns before, during, and after intraperitoneal (IP) chemotherapy and their impact on quality of life (QOL)
- timeFrame
- 6 months from study entry
- measure
- Length of hospitalization, ICU admission rates, clinic visits, phone calls, urgent care visits, and other heath system encounters
- timeFrame
- 6 months from study entry
- measure
- Development of palliative care assessment measures and interventions that apply to IP chemotherapy
- timeFrame
- 6 months from study start
- measure
- Implementation of a palliative care intervention
- timeFrame
- 6 months from study entry
- measure
- Impact of implementing palliative care interventions on resource utilization, improved QOL and symptoms, and number of chemotherapy courses completed
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Diagnosis of ovarian cancer * Under the care of the Medical Oncology Department at the City of Hope National Medical Center * Undergoing intraperitoneal chemotherapy PATIENT CHARACTERISTICS: * Life expectancy \> 6 months * Speaks English or Spanish PRIOR CONCURRENT THERAPY: * See Disease Characteristics
References
Publications (0)
Data not yet available
No reference posted for this study.